| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |